There is huge demand, but producing peptide drugs in large quantities is proving a challenge for Novo and Lilly
Thats the main difference
But the transition period, especially during the first few weeks or after dose increases, can produce blood sugar patterns that the body has not yet adapted to
As described earlier, we are revising 180.50(b)(2)(ii)(C) to require, at new 180.50(b)(2)(ii)(C)( 2 ), that, beginning January 1, 2026, if a payer-specific negotiated charge is based on a percentage or algorithm, the hospital must calculate and encode the 10th percentile, median, and 90th percentile allowed amounts in dollars for that item or service, but delaying enforcement until April 1, 2026
TCF7L2 Is a Master Regulator of Insulin Production and Processing. Zhuang, Langen, et al